COVID-19 Clinical Trial
— C19SurveyOfficial title:
How Are You Coping? Assessing the Psychological, Social, and Economic Impacts of an Emerging Pandemic
NCT number | NCT04369690 |
Other study ID # | 2131 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | April 3, 2020 |
Est. completion date | April 3, 2021 |
A dynamic analytical tool is being implemented to monitor the health, psychosocial and economic impacts of the COVID-19 pandemic as the crisis unfolds. A longitudinal survey is distributed via a network of hospitals, provincial/national organizations and web platforms. The survey information can be linked to provincial health administrative data and metrics derived from social media activity based on artificial intelligence methods. Targeted questions are included for critical populations such as healthcare workers and people with chronic illnesses.
Status | Recruiting |
Enrollment | 1000 |
Est. completion date | April 3, 2021 |
Est. primary completion date | April 3, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 12 Years and older |
Eligibility |
Inclusion Criteria: - All individuals who are at least 12 years of age Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
Canada | Hôpital en santé mentale Rivière-des-Prairies (CIUSSS du Nord-de-l'Île-de-Montréal) | Montréal | Quebec |
Canada | McGill University | Montréal | Quebec |
Canada | University of Montréal | Montréal | Quebec |
Canada | Southlake Regional Health Centre | Newmarket | Ontario |
Canada | CHEO Research Institute | Ottawa | Ontario |
Canada | The Centre for Addiction and Mental Health | Ottawa | Ontario |
Canada | The Ottawa Hospital Research Institute | Ottawa | Ontario |
Canada | The Royal's Institute of Mental Health Research | Ottawa | Ontario |
Canada | The University of Ottawa Heart Institute | Ottawa | Ontario |
Canada | Sunnybrook Health Sciences Centre | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
University of Ottawa | Centre for Addiction and Mental Health, Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal, CHEO Research Institute, Hopital du Sacre-Coeur de Montreal, Johns Hopkins University, McGill University, Ottawa Heart Institute Research Corporation, Southlake Regional Health Centre, Sunnybrook Health Sciences Centre, The Ottawa Hospital Research Institute, The Royal's Institute of Mental Health Research, Université de Montréal |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mental health - Stress | Cohen's Perceived Stress Scale (scores ranged from 0 to 40, higher scores indicating worse stress) | through study completion, estimated to 8 months | |
Primary | Mental health - Anxiety | Generalized Anxiety Disorder Scale (scores ranged from 0 to 21, higher scores indicating worse anxiety) | through study completion, estimated to 8 months | |
Primary | Mental health - Depression | Quick Inventory of Depressive Symptomatology-Self-report, short version (scores ranged from 0 to 27, higher scores indicating worse depression) | through study completion, estimated to 8 months | |
Secondary | Moral distress in healthcare workers | Measure of Moral Distress - Healthcare Professionals (scores ranged from 0 to 432, higher scores indicating worse moral distress) | through study completion, estimated to 8 months | |
Secondary | Moral resilience in healthcare workers | Rushton Moral Resilience Scale (scores ranged from 1 to 4, higher scores indicating more resiliency) | through study completion, estimated to 8 months | |
Secondary | Social life | Frequency of interacting with other people (daily, weekly, monthly, less often than monthly) | through study completion, estimated to 8 months | |
Secondary | COVID-9 symptoms | Fever, Cough, Difficulty breathing or shortness of breath, Tiredness, Aches and pains, Nasal congestion, Runny nose, Sore throat, Diarrhea (Mild Moderate, Severe, N/A) | through study completion, estimated to 8 months | |
Secondary | Adverse health long-term outcome | Mortality (Yes/No): https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx | 5 years before the outbreak and two years after | |
Secondary | Health care utilization - Inpatient | Hospitalizations (total number): https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx | 5 years before the outbreak and two years after | |
Secondary | Health care utilization - ER | Emergency Department visits (Total number): https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx | 5 years before the outbreak and two years after | |
Secondary | Health care utilization - Outpatient | Outpatient visits: https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx | 5 years before the outbreak and two years after | |
Secondary | Sleep | Pittsburgh Sleep Quality Index (scores ranged from 0 to 21, higher scores indicating worse sleep disturbances) | through study completion, estimated to 8 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|